RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,943,262 | -70.8% | 907,616 | -71.4% | 0.04% | -68.4% |
| Q2 2023 | $23,740,997 | -26.2% | 3,178,179 | -34.1% | 0.13% | -39.3% |
| Q1 2023 | $32,187,653 | -13.5% | 4,825,735 | 0.0% | 0.22% | +25.9% |
| Q4 2022 | $37,206,417 | -23.8% | 4,825,735 | +5.2% | 0.17% | -39.6% |
| Q3 2022 | $48,809,000 | +30.7% | 4,587,274 | 0.0% | 0.29% | -50.1% |
| Q2 2022 | $37,341,000 | +13.7% | 4,587,274 | 0.0% | 0.58% | +43.5% |
| Q1 2022 | $32,845,000 | -51.1% | 4,587,274 | +16.9% | 0.40% | -40.9% |
| Q4 2021 | $67,213,000 | -25.6% | 3,923,713 | 0.0% | 0.68% | +78.9% |
| Q3 2021 | $90,285,000 | -35.9% | 3,923,713 | +1.7% | 0.38% | -51.4% |
| Q2 2021 | $140,839,000 | – | 3,858,617 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |